4
Changes in Ownership
KESTRA MEDICAL TECHNOLOGIES, LTD. Filed Acc 0001193125-26-438722
Chief Financial Officer sold 79,500 shares at an average $30.30 ($2,408,590)
- Chief Financial Officer acquired 79,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mahboob Vaseem Chief Financial Officer | 2026-10-27 | Option exercise 10b5-1 | +34,809 | $17.00 | $591,753 | 95,418 | D |
| Mahboob Vaseem Chief Financial Officer | 2026-10-27 | Sale 10b5-1 | −34,809 | $30.04 | $1,045,784 | 60,609 | D |
| Mahboob Vaseem Chief Financial Officer | 2026-10-28 | Option exercise 10b5-1 | +39,903 | $17.00 | $678,351 | 100,512 | D |
| Mahboob Vaseem Chief Financial Officer | 2026-10-28 | Sale 10b5-1 | −39,903 | $30.48 | $1,216,303 | 60,609 | D |
| Mahboob Vaseem Chief Financial Officer | 2026-10-29 | Option exercise 10b5-1 | +4,788 | $17.00 | $81,396 | 65,397 | D |
| Mahboob Vaseem Chief Financial Officer | 2026-10-29 | Sale 10b5-1 | −4,788 | $30.60 | $146,503 | 60,609 | D |
| Derivatives | |||||||
| Mahboob Vaseem Chief Financial Officer | 2026-10-27 | Option exercise · Options 10b5-1 | −34,809 | 124,191 | D | ||
| Mahboob Vaseem Chief Financial Officer | 2026-10-28 | Option exercise · Options 10b5-1 | −39,903 | 84,288 | D | ||
| Mahboob Vaseem Chief Financial Officer | 2026-10-29 | Option exercise · Options 10b5-1 | −4,788 | 79,500 | D | ||
| Open-market sales · 79,500 sh · avg $30.30 · $2,408,590 | |||||||
Loading xslF345X06/ownership.xml…